MIR3910-1

Across TCGA pan-cancer cohorts, MIR3910-1 RNA is linked to patient survival in 2 of 34 cancer types, making it the most broadly survival-associated MIR3910-1 data layer.

The strongest signal is observed in sarcoma (SARC), where higher MIR3910-1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MIR3910-1 expression acts as an unfavorable survival marker, although some lineages such as LAML show a favorable association.

SARC and LAML are the cancer types where MIR3910-1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SARC	DFS	Tertile	All	0.085	0.595	<.001	9	view →
LAML	DFS	Tertile	All	0.945	0.548	.039	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

MIR3910-1–SARC (DFS)

Open the SARC breakdown →